ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977

NCI CTEP-Approved Trials For the Month of February

February 28, 2014

New Edition Of Book On Cancer Rates, Risks, Available

February 28, 1997

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007